Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...